...
首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation.
【24h】

Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation.

机译:肝硬化患者中纤溶酶和抗纤溶因子(组织型纤溶酶原激活物和纤溶酶原激活物抑制剂1型)的严重失衡和严重出血的情况:通过肝移植进行纠正。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

SUMMARY: A 49-year-old male with alcoholic cirrhosis suffered several spontaneous, life-threatening, deep muscle bleeding episodes. Laboratory evaluation indicated excessive fibrinolysis with low plasminogen, low alpha2-antiplasmin, undetectable plasminogen activator inhibitor type 1 (PAI-1) activity, high tissue plasminogen activator (t-PA) activity and high t-PA antigen. Treatment with oral anti-fibrinolytic agents prevented further bleeding episodes. Decompensated cirrhosis eventually necessitated orthotopic liver transplantation. Post-operatively, the patient did not require oral anti-fibrinolytic agents, and there were no significant bleeding events. Circulating PAI-1 activity, t-PA activity and antigen normalized by 3 months post transplant. In short, the profound bleeding diathesis, as well as the imbalance in t-PA and PAI-1 levels, corrected after liver transplantation. Recognition of such patients is important, because the bleeding diathesis is an indication rather than a contraindication for orthotopic liver transplantation.
机译:摘要:一名患有酒精性肝硬化的49岁男性经历了数次自发性,威胁生命的深层肌肉出血发作。实验室评估表明,纤维蛋白溶解过度,纤溶酶原含量低,α2-抗纤溶酶蛋白含量低,纤溶酶原激活物抑制剂1型(PAI-1)活性低,组织纤溶酶原激活物(t-PA)活性高,t-PA抗原含量高。口服抗纤维蛋白溶解剂治疗可防止进一步的出血发作。代偿性肝硬化最终需要原位肝移植。术后,患者不需要口服抗纤溶剂,也没有明显的出血事件。移植后3个月使循环中的PAI-1活性,t-PA活性和抗原恢复正常。简而言之,肝移植后可纠正严重的出血素质,以及t-PA和PAI-1水平的失衡。对此类患者的识别很重要,因为出血的素质是原位肝移植的指征而不是禁忌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号